Login / Signup

Personalized, interdisciplinary patient pathway for cross-sector care of multimorbid patients (eliPfad trial): study protocol for a randomized controlled trial.

Christoph Heinrich LindemannVolker BurstLinus Alexander VölkerSebastian BrählerDusan SimicIngrid BeckerMartin HellmichClarissa KurscheidNadine ScholtenRuben KrauspeKerstin LeibelStephanie StockPaul Thomas Brinkkoetter
Published in: Trials (2024)
The trial was registered in the German Clinical Trials Registry (Deutsches Register Klinischer Studien (DRKS)) on 08/14/2023 under the ID DRKS00031500 .
Keyphrases
  • clinical trial
  • phase iii
  • phase ii
  • end stage renal disease
  • study protocol
  • healthcare
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • palliative care
  • prognostic factors